Entity Details

Primary name PANK2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9BZ23
EntryNamePANK2_HUMAN
FullNamePantothenate kinase 2, mitochondrial
TaxID9606
Evidenceevidence at protein level
Length570
SequenceStatuscomplete
DateCreated2003-01-17
DateModified2021-06-02

Ontological Relatives

GenesPANK2

GO terms

Show/Hide Table
GOName
GO:0001525 angiogenesis
GO:0004594 pantothenate kinase activity
GO:0005524 ATP binding
GO:0005634 nucleus
GO:0005739 mitochondrion
GO:0005758 mitochondrial intermembrane space
GO:0005829 cytosol
GO:0007286 spermatid development
GO:0009060 aerobic respiration
GO:0015937 coenzyme A biosynthetic process
GO:0015939 pantothenate metabolic process
GO:0016310 phosphorylation
GO:0019217 regulation of fatty acid metabolic process
GO:0051881 regulation of mitochondrial membrane potential
GO:0070584 mitochondrion morphogenesis
GO:0090207 regulation of triglyceride metabolic process
GO:1904251 regulation of bile acid metabolic process

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Mitochondrion
Mitochondrion intermembrane space
Nucleus

Domains

Show/Hide Table
DomainNameCategoryType
IPR004567 Type II pantothenate kinaseFamilyFamily
IPR043129 ATPase, nucleotide binding domainFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
607236 OMIMHypoprebetalipoproteinemia, acanthocytosis, retinitis pigmentosa, and pallidal degeneration (HARP)Rare syndrome with many clinical similarities to PKAN. The disease is caused by variants affecting the gene represented in this entry.
234200 OMIMNeurodegeneration with brain iron accumulation 1 (NBIA1)Autosomal recessive neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. Clinical manifestations include progressive muscle spasticity, hyperreflexia, muscle rigidity, dystonia, dysarthria, and intellectual deterioration which progresses to severe dementia over several years. It is clinically classified into classic, atypical, and intermediate phenotypes. Classic forms present with onset in first decade, rapid progression, loss of independent ambulation within 15 years. Atypical forms have onset in second decade, slow progression, maintenance of independent ambulation up to 40 years later. Intermediate forms manifest onset in first decade with slow progression or onset in second decade with rapid progression. Patients with early onset tend to also develop pigmentary retinopathy, whereas those with later onset tend to also have speech disorders and psychiatric features. All patients have the 'eye of the tiger' sign on brain MRI. The disease is caused by variants affecting the gene represented in this entry.